BIO-key Secures Another Middle East Government Contract for its Passwordless, Biometric, Identity and Access Management SolutionsGlobeNewsWire · 3 days ago
Bio-Rad Laboratories Inc (BIO) Stock Down 3.0% but Still Overvalued -- GF Score: 73/100GuruFocus · Oct 16, 2026
Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026Business Wire · Oct 14, 2026
BIO-key Names Cybersecurity Veteran Stephen Morrow President of PortalGuard to Drive Accelerated Adoption of its Innovative IAM SolutionGlobeNewsWire · Oct 13, 2026
BIO-key Adds New Middle East Government Security Agency Customer, Expanding Regional FootprintGlobeNewsWire · Oct 13, 2026
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor PlatformGlobeNewsWire · Oct 7, 2026Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $1.75 | $2.62 | Beat |
| Apr 30, 2026 | $1.97 | $1.89 | Miss |
| Feb 12, 2026 | $2.57 | $2.51 | Miss |
| Oct 29, 2025 | $2.30 | $2.26 | Miss |
| Jul 31, 2025 | $1.93 | $2.61 | Beat |
| May 1, 2025 | $1.73 | $2.54 | Beat |